Scibase AB (SCIB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Scibase AB (SCIB) has a cash flow conversion efficiency ratio of -0.457x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-26.57 Million ≈ $-2.86 Million USD) by net assets (Skr58.11 Million ≈ $6.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Scibase AB for the company's overall valuation and market capitalisation.
Scibase AB - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Scibase AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Scibase AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Scibase AB ranked by their cash flow conversion efficiency. See Scibase AB cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
J and Friends Holdings Limited
NASDAQ:JF
|
-43.621x |
|
Kainos Group PLC
LSE:KNOS
|
0.490x |
|
N.C. Housing Public Company Limited
BK:NCH
|
0.024x |
|
SUNL.TECH.G.ADR/2DL-00005
F:S790
|
N/A |
|
Four Seasons Education Cayman
NYSE:FEDU
|
N/A |
|
Trigon Metals Inc
V:TM
|
0.321x |
|
Fiplasto SA
BA:FIPL
|
-0.024x |
|
Scan Inter PCL
BK:SCN
|
0.030x |
Annual Cash Flow Conversion Efficiency for Scibase AB (2012–2025)
The table below shows the annual cash flow conversion efficiency of Scibase AB from 2012 to 2025. View Scibase AB (SCIB) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr6.66 Million ≈ $716.29K |
Skr-84.58 Million ≈ $-9.10 Million |
-12.707x | -711.59% |
| 2024-12-31 | Skr36.65 Million ≈ $3.94 Million |
Skr-57.38 Million ≈ $-6.18 Million |
-1.566x | -29.68% |
| 2023-12-31 | Skr43.06 Million ≈ $4.63 Million |
Skr-51.98 Million ≈ $-5.59 Million |
-1.207x | +31.48% |
| 2022-12-31 | Skr25.24 Million ≈ $2.72 Million |
Skr-44.47 Million ≈ $-4.79 Million |
-1.762x | -215.78% |
| 2021-12-31 | Skr70.80 Million ≈ $7.62 Million |
Skr-39.50 Million ≈ $-4.25 Million |
-0.558x | +22.78% |
| 2020-12-31 | Skr46.86 Million ≈ $5.04 Million |
Skr-33.86 Million ≈ $-3.64 Million |
-0.723x | +39.05% |
| 2019-12-31 | Skr32.01 Million ≈ $3.45 Million |
Skr-37.96 Million ≈ $-4.08 Million |
-1.186x | -126.10% |
| 2018-12-31 | Skr71.48 Million ≈ $7.69 Million |
Skr-37.48 Million ≈ $-4.03 Million |
-0.524x | -37.36% |
| 2017-12-31 | Skr115.72 Million ≈ $12.45 Million |
Skr-44.18 Million ≈ $-4.75 Million |
-0.382x | -47.93% |
| 2016-12-31 | Skr185.41 Million ≈ $19.95 Million |
Skr-47.85 Million ≈ $-5.15 Million |
-0.258x | -61.43% |
| 2015-12-31 | Skr291.42 Million ≈ $31.36 Million |
Skr-46.59 Million ≈ $-5.01 Million |
-0.160x | +85.92% |
| 2014-12-31 | Skr32.65 Million ≈ $3.51 Million |
Skr-37.08 Million ≈ $-3.99 Million |
-1.136x | -20.76% |
| 2013-12-31 | Skr36.18 Million ≈ $3.89 Million |
Skr-34.03 Million ≈ $-3.66 Million |
-0.940x | -161.14% |
| 2012-12-31 | Skr-23.69 Million ≈ $-2.55 Million |
Skr-36.44 Million ≈ $-3.92 Million |
1.538x | -- |
About Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more